High Prophylactic Efficacy of Thymol Loaded Chitosan Nanoparticles for Controlling Acute Toxoplasmosis in Mice
Open Access
- 9 March 2025
- journal article
- Published by Knowledge E DMCC in Iranian Journal of Parasitology
- Vol. 20 (1) , 100-110
Abstract
Background: Given the significant role of chitosan nanoparticles in medicine, the present study aimed to assess the in vivo efficacy of synthesized chitosan nanoparticles coated with thymol (CNCT) in combating Toxoplasma gondii infection. Methods: Mice were administered CNCT orally at dosages ranging from 0.25 to 0.75 mg/kg/day for a duration of 14 days. Following this treatment, they were infected with T. gondii tachyzoites of the Rh strain to induce acute toxoplasmosis. Then, the mortality rate, parasite load, antioxidant activity, and the gene expression level of proinflammatory cytokines were evaluated. Results: The dimensions of CNTN exhibit variability, with a mean size of 295 nm. The prophylactic administration of CNTN in mice infected with T. gondii resulted in a significant enhancement in survival rates and a considerable decrease in parasite load (P<0.001). The CNTN caused a significant decrease in malondialdehyde level, while a notable increase (P < 0.001) in the activity of the antioxidant enzymes. The feeding the mice infected with CNTN caused a meaningful elevation in the expression level of TNFα- and IL-1β (P<0.001). The biochemical analyses indicated no significant changes in the serum levels of liver and kidney function markers. Conclusion: The recent study revealed that CNTN demonstrates promising in vivo effects against toxoplasmosis in murine models. These effects are attributed to its antioxidant properties and immunomodulatory capabilities, which increase specific pro-inflammatory cytokines without any noticeable signs of toxicity to liver and kidney function.Keywords
This publication has 27 references indexed in Scilit:
- Antibacterial and antifungal activities of thymol: A brief review of the literatureFood Chemistry, 2016
- Anti-ToxoplasmaActivity of Estragole and Thymol in Murine Models of Congenital and Noncongenital ToxoplasmosisJournal of Parasitology, 2016
- Novel therapeutic strategies for treatment of visceral leishmaniasisDrug Discovery Today, 2013
- A review on human toxoplasmosisScandinavian Journal of Infectious Diseases, 2012
- In VitroandIn VivoAntimalarial Activity of Essential Oils and Chemical Components from Three Medicinal Plants Found in Northeastern BrazilPlanta Medica, 2012
- IN VITRO AND IN VIVO ANTI-PLASMODIAL ACTIVITY OF ESSENTIAL OILS, INCLUDING HINOKITIOL2012
- Parasitic infection and oxidative status are associated and vary with breeding activity in the Seychelles warblerProceedings Of The Royal Society B-Biological Sciences, 2011
- The role of earlyin vivotoxicity testing in drug discovery toxicologyExpert Opinion on Drug Safety, 2008
- ROLE OF TNF AND IL-1 IN INFECTIONS WITH TOXOPLASMA-GONDII1990
- Activity of recombinant tumor necrosis factor on Toxoplasma gondii and Trypanosoma cruzi.The Journal of Immunology, 1986